| Trial ID: |  L0067 | 
                      | Source ID: |  NCT03796975
                       | 
                      | Associated Drug: | 
                        
                          Pioglitazone
                        
                       | 
                      | Title: | 
                        
                          Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease
                        
                       | 
                      | Acronym: | 
                        
                        --
                        
                       | 
                      | Status: | 
                        
                          Completed
                        
                       | 
                      | Study Results: | 
                        
                          No Results Available
                        
                       | 
                      | Results: | 
                        
                        --
                        
                       | 
                      | Conditions: | 
                        
                        Type 2 Diabetes Mellitus|Non-alcoholic Fatty Liver Disease|Efficacy
                        
                       | 
                      | Interventions: | 
                      
                          Drug: Combination of Pioglitazone and Metformin Tablets|Drug: Metformin Hydrochloride Tablets
                        
                       | 
                      | Outcome Measures: | 
                      
                          Decreased of liver fat content of fatty liver after 24 weeks treatment as assessed by B-ultrasound|Change of B-cell function after 24 weeks treatment as assessed by homeostasis model assessment of insulin resistance index|Change of liver enzyme after 24 weeks treatment as assessed by blood test|Decreased of HbA1c after 24 weeks treatment as assessed by blood test|Decreased of fasting blood glucose after 24 weeks treatment as assessed by blood test|Change of weight and waistline after 24 weeks treatment as assessed by standard measurement
                        
                       | 
                      | Sponsor/Collaborators: | 
                      
                          Xijing Hospital|Second Affiliated Hospital of Xi'an Jiaotong University|Shaanxi Aerospace Hospital|Genertec Universal Xi'an Aero-Engine hospital (Xi' an) Co., Ltd|Xi'an Gaoxin Hospital|Chang'An Hospital|Yan'an people's Hospital|Shangluo Central Hospital
                        
                       | 
                      | Gender: | 
                      
                          All
                        
                       | 
                      | Age: | 
                      
                          18 Years to 70 Years ?? (Adult, Older Adult)
                        
                       | 
                      | Phases: | 
                      
                          Phase 4
                        
                       | 
                      | Enrollment: | 
                      
                          120
                        
                       | 
                      | Study Type: | 
                      
                          Interventional
                        
                       | 
                      | Study Designs: | 
                      
                          Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
                        
                       | 
                      | Start Date: | 
                      
                          June 28, 2018
                        
                       | 
                      | Completion Date: | 
                      
                          November 20, 2019
                        
                       | 
                      | Results First Posted: | 
                      
                        --
                        
                       | 
                      | Last Update Posted: | 
                      
                          August 7, 2020
                        
                       | 
                      | Locations: | 
                      
                          Xijing Hospital, Fourth Military Medical university, Xi'an, Shaanxi, China
                        
                       | 
                      | URL: | 
                      
                          https://ClinicalTrials.gov/show/NCT03796975
                        
                       |